Legionella: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*First line | |||
==Differential Diagnosis== | |||
{{Causes of pneumonia}} | |||
==Management== | |||
*First line | |||
**[[Azithromycin]] | |||
*Alternatives: | *Alternatives: | ||
**Doxycycline | **[[Doxycycline]] | ||
**Tigecycline | **[[Tigecycline]] | ||
**Respiratory fluoroquinolone for severe disease<ref>Burke et Al. Legionnaires Disease Treatment & Management. Aug 18, 2014. http://emedicine.medscape.com/article/220163-treatment#d11</ref> | **Respiratory [[fluoroquinolone]] for severe disease<ref>Burke et Al. Legionnaires Disease Treatment & Management. Aug 18, 2014. http://emedicine.medscape.com/article/220163-treatment#d11</ref> | ||
==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>== | ==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>== | ||
Revision as of 13:19, 5 June 2016
Background
Differential Diagnosis
Causes of Pneumonia
Bacteria
Viral
- Common
- Influenza
- Respiratory syncytial virus
- Parainfluenza
- Rarer
- Adenovirus
- Metapneumovirus
- Severe acute respiratory syndrome (SARS)
- Middle east respiratory syndrome coronavirus (MERS)
- 2019-nCoV (COVID-19)
- Cause other diseases, but sometimes cause pneumonia
Fungal
- Histoplasmosis
- Coccidioidomycosis
- Blastomycosis
- Pneumocystis jirovecii pneumonia (PCP)
- Sporotrichosis
- Cryptococcosis
- Aspergillosis
- Candidiasis
Parasitic
Management
- First line
- Alternatives:
- Doxycycline
- Tigecycline
- Respiratory fluoroquinolone for severe disease[1]
Antibiotic Sensitivities[2]
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
Table Overview
| ||||||||||||||||||||||||||||||||||||||||
See Also
References
- ↑ Burke et Al. Legionnaires Disease Treatment & Management. Aug 18, 2014. http://emedicine.medscape.com/article/220163-treatment#d11
- ↑ Sanford Guide to Antimicrobial Therapy 2014